NBP Form 6-K: Report of foreign private issuer, 2024

NovaBridge Biosciences Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2024-12-03: Form 6-K; Period of report 2024-12-03; Description 6-K; Document investor_presentation_12.htm.
2024-11-14: Form 6-K; Period of report 2024-11-14; Description 6-K; Document i_-_mab_6k_q3_2024.htm.
2024-11-06: Form 6-K; Period of report 2024-11-06; Description 6-K; Document sean_fu_ceo_appt_11.6.20.htm.
2024-11-05: Form 6-K; Period of report 2024-11-05; Description 6-K; Document inhibrix_litigation.htm.

Filed	Form	Period of report	Description	Document
2024-12-03	6-K	2024-12-03	6-K	investor_presentation_12.htm
2024-11-14	6-K	2024-11-14	6-K	i_-_mab_6k_q3_2024.htm
2024-11-06	6-K	2024-11-06	6-K	sean_fu_ceo_appt_11.6.20.htm
2024-11-05	6-K	2024-11-05	6-K	inhibrix_litigation.htm
2024-10-24	6-K	2024-10-24	6-K	q32024_ir_presentation.htm
2024-09-23	6-K	2024-09-23	6-K	board_resignation_chen_9.htm
2024-09-16	6-K	2024-09-16	6-K	giva_esmo_data_pr_091620.htm
2024-08-30	6-K	2024-08-30	6-K	2nd_agreement_abio-x_8.3.htm
2024-08-28	6-K	2024-08-28	6-K	i_-_mab_6k_mid_year_2024.htm
2024-08-07	6-K	2024-08-07	FORM 6-K	tm2421036d1_6k.htm
2024-07-15	6-K	2024-07-15	FORM 6-K	tm2419452d1_6k.htm
2024-06-06	6-K	2024-06-05	FORM 6-K	tm2416488d2_6k.htm
2024-06-05	6-K	2024-06-05	FORM 6-K	tm2416488d1_6k.htm
2024-05-23	6-K	2024-05-23	FORM 6-K	tm2415467d1_6k.htm
2024-04-15	6-K	2024-04-15	FORM 6-K	tm2411834d1_6k.htm
2024-04-02	6-K	2024-04-02	FORM 6-K	tm2410624d1_6k.htm
2024-04-01	6-K	2024-04-01	FORM 6-K	tm2410304d1_6k.htm
2024-03-15	6-K	2024-03-15	FORM 6-K	tm248949d1_6k.htm
2024-02-07	6-K	2024-02-07	FORM 6-K	tm245234d1_6k.htm
2024-02-06	6-K	2024-02-06	FORM 6-K	tm245313d1_6k.htm